Jupiter Neurosciences (JUNS) Earnings Date & Reports
Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
JUNS is expected to report earnings to fall 16.67% to -5 cents per share on September 02
Q2'26
Est.
$-0.05
Q1'26
Missed
by $0.01
Q4'25
Est.
$-0.07
Q3'25
Est.
$-0.08
Q2'25
Est.
$-0.07
The last earnings report on May 14 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 3.26M shares outstanding, the current market capitalization sits at 11.09M.